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Conclusions: The mean VAP rate and VAP associated mor-
tality at our hospital was less than that reported by NNIS
System surveillance. Head trauma was the major risk factor
for development of VAP. Prophylactic antibiotic use is preva-
lent in our unit. Etiologically, gram negatives predominated
with MRSA being uncommon. Piperacillin-tazobactam and
carbapenems were the favoured treatment choices. Addi-
tional studies are necessary for comparison and establishing
antibiotic guidelines for treating ventilator associated pneu-
monia in the UAE.
doi:10.1016/j.ijid.2008.05.982
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Background: The aims of this study were to develop a
sensitive VRE screening procedure at National University
Hospital (NUH), Singapore. The processes needed to be prac-
tical and to utilise available resources optimally.
Methods: The study was conducted in speciﬁc high risk
wards of NUH notably, haematology-oncology, ICUs, long-
term care, neurology and nephrology. The intervention
involved active surveillance and focused on 3 major com-
ponents to determine who would be swabbed; a risk index
score for all patients, universal screening for all patients
admitted from speciﬁc locations in Singapore and interval
swabbing of all long stay patients. The risk index score
was undertaken by assigning weighted point values based
on local experience of risk factors associated with patients’
harbouring VRE. No pre emptive isolation was included but
strict contact precautions were emphasised for patients with
results pending. The (pre intervention) comparison group in
this study were patients that were screened for VRE from
speciﬁc hospitals on admission to NUH, patients who had
contact with VRE patients and patients whose was stool sent
for Clostridium difﬁcile cytotoxin assay between Apr 2005
and Oct 2007. These had been cultured for VRE as part of a
research project
Results: The VRE detected was 11.09 per 1000 VRE swabs
compared to 15.4 per 1000 VRE swabs before the interven-
tion; p = 0.428. Average cost of isolation ranging $157 to $798
post intervention compared to before intervention, $1968 to
$3985.
Conclusion: A larger sample size is required to evaluate
efﬁciency of VRE screening procedure. However, the inter-
vention has resulted in better bed allocation, identiﬁcation
of high-risk patients for VRE from external facilities and
within NUH; and reduction in the hospitalization cost for
the patients.
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Background: Permanent pacemaker (PPM) and
implantable desﬁbrillator-cardioverter (IDC)-related
endocarditis is a infection that is associated with a sub-
stantial morbidity and mortality and also with a signiﬁcant
ﬁnancial cost.
Methods: Observational and retrospective study. Setting:
700-bed tertiary hospital. Period: January 1996 to Decem-
ber 2006. PM and IDC inserted during this period were
1224 and 188 respectively. Cardiac device-related infective
endocarditis (CDIE) was deﬁned as the presence of both
vegetation on a device lead or valve and clinical or microbi-
ological evidence of CDIE.
Results: 27 patients fulﬁlled the CDIE criteria, 20 had
a PPM and 7 an IDC. Incidence of PPM and ID related
endocarditis were 1.8% and 3.1% respectively. Mean age 70
(range: 24 to 86 years). 70% were male. 12 had underly-
ing cardiac conditions. 59% had early local complications (7
displacements, 9 hematomas or seromas). 52% had previ-
ous manipulations of the generator and/or the leads. Mean
time between insertion and CDIE was 66months (SD± 57). 23
patients had late endocarditis and 4 early one. Most frequent
pathogens were coagulase negative staphylococcus 37%,
Staphylococcus aureus 30% and Enterococcus faecalis15%.
Most frequent antibiotics used were: cloxacillin 11, van-
comycin 5, teicoplanin 2 and ampicilin 5. 89% of patients
received combined treatment with an aminoglucosid (21) or
rifampin (3). Intravenous treatment length was 34 days (±8).
52% patients prolonged antibiotic therapy by oral route. In
16 patients leads were replaced (44% by traction and 56% by
open surgery). Complications were 2 septic emboli, 7 septic
shock and attributable mortality was 1%.
Conclusion:
- Incidence of PPM and ID related endocarditis were 1.8%
and 3.1% respectively.
- 60% of patients have had precocious local complications
time before cardiac device-endocarditis diagnosis.
- Most were caused by grampositive cocci.
- More than 50% received prolonged courses of oral antibi-
otics after completing intravenous treatment.
doi:10.1016/j.ijid.2008.05.984
